Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis

Kidney International

Volumn 88, Issue 1, 2015, Pages 61-71

  Colombaro, Vanessa ^a   Jadot, Inès ^a   Declèves, Anne Emilie ^a,b   Voisin, Virginie ^a   Giordano, Laetitia ^a   Habsch, Isabelle ^a   Malaisse, Jérémy ^a   Flamion, Bruno ^a   Caron, Nathalie ^a  

^a University of Namur   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Acute kidney injury; Cytokines; Fibrosis; Ischemia reperfusion

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CREATININE; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; PROTEIN HYAL1; PROTEIN HYAL2; UNCLASSIFIED DRUG; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; CCL2 PROTEIN, MOUSE; CD44 PROTEIN, MOUSE; CXCL2 CHEMOKINE; CXCL2 PROTEIN, MOUSE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HYAL1 PROTEIN, MOUSE; HYAL2 PROTEIN, MOUSE; HYALURONOGLUCOSAMINIDASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE EXACERBATION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; KNOCKOUT MOUSE; MALE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; WILD TYPE; ACUTE KIDNEY INJURY; ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; DEFICIENCY; FIBROSIS; GENETICS; KIDNEY; KIDNEY TUBULE; LEUKOCYTE COUNT; METABOLISM; MUCOPOLYSACCHARIDOSIS; NEUTROPHIL; PATHOLOGY;

ACTINS; ACUTE KIDNEY INJURY; ANIMALS; ANTIGENS, CD44; CHEMOKINE CCL2; CHEMOKINE CXCL2; COLLAGEN TYPE I; COLLAGEN TYPE III; CREATININE; FIBROSIS; GPI-LINKED PROTEINS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; KIDNEY; KIDNEY TUBULES; LEUKOCYTE COUNT; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOPOLYSACCHARIDOSES; NEPHRITIS; NEUTROPHILS; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84934442455     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.53     Document Type: Article

References (34)

1. Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 1997; 64: 945-957.
2. Barri MY, Sanchez QE, Jennings WL et al. Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl 2009; 15: 475-483.
3. Bonventre VJ, Weinberg MJ. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210.
4. Forbes MJ, Hewitson DT, Becker JG et al. Ischemic acute renal failure: long term histology of cell and matrix changes in the rat. Kidney Int 2000; 57: 2375-2385.
5. Bajwa A, Kinsey RG, Okusa DM. Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets 2009; 10: 1196-1204.
6. Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997; 242: 27-33.
7. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003; 13: 105-115.
8. Hansell P, Göransson V, Odlind C et al. Hyaluronan concentration in the kidney in different states of body hydration. Kidney Int 2000; 58: 2061-2068.
9. Hällgren R, Gerdin B, Tufverson G. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. J Exp Med 1990; 171: 2063-2076.
10. Campo MG, Avenoso A, Nastasi G et al. Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochim Biophys Acta 2011; 9: 1170-1181.
11. Wells A, Larsson E, Fellström B et al. Role of hyaluronan in chronic and acutely rejecting kidneys. Transplant Proc 1993; 25: 2048-2049.
12. Johnsson C, Tufveson G, Wahlberg J et al. Experimentally-induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int 1996; 50: 1224-1229.
13. Declèves AE, Caron N, Nonclercq D et al. Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia/reperfusion injury. Int J Mol Med 2006; 18: 83-94.
14. Declèves AE, Caron N, Voisin V et al. Synthesis and fragmentation of hyaluronan in renal ischemia. Nephrol Dial Transplant 2012; 27: 3771-3781.
15. Colombaro V, Declèves AE, Jadot I et al. Inhibition of hyaluronan is protective against renal ischemia-reperfusion injury. Nephrol Dial Transplant 2013; 28: 2484-2493.
16. Han HD, Song KH, Lee YS et al. Upregulation of hyaluronan and its binding receptors in an experimental model of chronic cyclosporine nephropathy. Nephrology 2010; 15: 216-224.
17. Jun Z, Hill AP, Lan YH et al. CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol 1997; 108: 69-77.
18. Rouschop MAK, Sewnath EM, Claessen N et al. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2004; 15: 674-686.
19. Göransson V, Johnsson C, Jacobson A et al. Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemiareperfusion injury in the rat. Nephrol Dial Transplant 2004; 19: 823-830.
20. Eldridge L, Moldobaeva A, Wagner EM. Increased hyaluronan fragmentation during pulmonary ischemia. Am J Physiol Lung Cell Mol Physiol 2011; 301: 782-788.
21. Teder P, Heldin P. Mechanism of impaired local hyaluronan turnover in bleomycin-induced lung injury in rat. Am J Respir Cell Mol Biol 1997; 17: 376-385.
22. Asselman M, Verhulst A, Van Ballegooijen SE et al. Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 2005; 68: 71-83.
23. Hwang I, Seo EY, Ha H. Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res 2009; 32: 1653-1662.
24. Beck-Schimmer B, Oertli B, Pasch T et al. Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol 1998; 9: 2283-2290.
25. Ysebaert KD, De Greef EK, Vercauteren RS et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15: 1562-1574.
26. Khan IA, Kerfoot MS, Heit B et al. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol 2004; 173: 7594-7601.
27. Rouschop MAK, Roelofs JTHJ, Claessen N et al. Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol 2005; 16: 2034-2043.
28. Persy PV, Verhulst A, Ysebaert KD et al. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 2003; 63: 543-553.
29. Basile PD, Donohoe D, Roethe K et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: 887-899.
30. Wüthrich PR. The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol Dial Transplant 1999; 14: 2554-2556.
31. Ruffel B, Johnsson P. The regulation and function of hyaluronan binding by CD44 in the immune system. J Immunol 2008; 181: 7044-7054.
32. Rouschop MAK, Claessen N, Pals TS et al. CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-1-induced apoptosis. J Am Soc Nephrol 2006; 17: 746-753.
33. Jadin L, Wu X, Ding H et al. Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX FASEB J 2008; 22: 316-4326.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)). Methods 2001; 25: 402-408.